Table 1.
SNP | Disease association | Reported effect on ANRIL expression |
---|---|---|
rs564398-A | Risk allele for diabetes and atherosclerotic stroke [65] | Reduced ANRIL expression (exons 1–2). Twice reported to exert the strongest influence in ANRIL expression in peripheral blood [21,23] |
rs1063192-C | Risk for glioma [16] and open angle glaucoma [6] | Increased ANRIL expression (exons 1–2) [21,23] |
rs1011970-T | Melanoma [13] | Reduced expression of ANRIL (exons 1–2) [23] |
rs2151280-T | Risk allele for plexiform neurofibroma development [64] and protective allele for BCC [11] | Reduced expression of ANRIL (exons 15–16) [64] |
rs3731217-G | Risk allele for Acute lymphoblastic leukemia [9] | Reduced expression of ANRIL (exons 17–18) [21] |
rs496892-G | Risk for atherosclerotic stroke [65] and periodontitis | Reduced ANRIL expression (exons 1–2) [21,23] |
rs10757278-G | Lead SNP for CAD risk [66] | Increased ANRIL variant EU741058 expression (exons 1–5 of the long transcript) [22], but reduced expression of ANRIL exons 1–2 [23]. |
rs3731257-G | Risk allele for ovarian cancer [15] | Increased expression of ANRIL (exons 1–2) [23] |
rs10811661-T | Risk allele for diabetes [2] | Reduced ANRIL expression (exons 1–2) [23] |
Exon numbers are based on the 19 exon transcript.